Received Jun 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
Lymphedema; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHOEDEMA (Lymphedema) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHOEDEMA (Lymphedema). At the time of the report, LYMPHOEDEMA (Lymphedema) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. No Concomitant medication was reported. She added that similar symptoms happened around 3 years ago, after Moderna vaccine, she started manual lymphatic drainage, for lymphedema after first episode. She contacted GP 3rd week in May for pain relief, and started manual lymphatic drainage again as was successful after 18 months. It was unknown if the patient experienced any additional symptoms/events. No treatment drug was reported. This case was linked to MOD-2025-787680 (Patient Link).